Application of gas chromatography-chemical ionization mass fragmentography in the evaluation of bases and nucleoside analogues used in cancer chemotherapy.
D000818:Animals; D000970:Antineoplastic Agents / Q000097:blood*; D001483:Base Sequence; D002849:Chromatography, Gas; D003561:Cytarabine / Q000031:analogs & derivatives / Q000097:blood / Q000652:urine; D004341:Drug Evaluation; D005467:Floxuridine / Q000031:analogs & derivatives / Q000097:blood / Q000652:urine; D005472:Fluorouracil / Q000031:analogs & derivatives / Q000097:blood; D013058:Mass Spectrometry / Q000379:methods*; D015122:Mercaptopurine / Q000031:analogs & derivatives / Q000097:blood; D008722:Methods; D008745:Methylation; D051379:Mice; D009705:Nucleosides / Q000097:blood*; D011687:Purines / Q000097:blood; D011743:Pyrimidines / Q000097:blood; D012263:Ribonucleosides / Q000652:urine
D000970:Antineoplastic Agents; D009705:Nucleosides; D011687:Purines; D011743:Pyrimidines; D012263:Ribonucleosides; D005467:Floxuridine; D003561:Cytarabine; D015122:Mercaptopurine; D005472:Fluorouracil